Abstract
There is increasing evidence that human tumors possess tumor-associated neo-antigens. The host mounts an immunological response to these antigens, as evidenced by the detection of circulating humoral antibodies in a variety of human neoplasia.
An indirect immunofluorescent antibody technique was employed to detect antibodies to tumor-associated antigens in the sera of patients with malignant gliomas. Viable single cell suspensions were used to demonstrate antibodies to surface contents of tumor cells and cell preparations were snap-frozen at −160° C to demonstrate antibodies to cytoplasmic components of tumor cells. After incubation with serum, the preparations were treated with polyvalent sheep antihuman globulin conjugated to isomer-1-fluorescein isothiocyanate, washed, and examined with a Leitz incident fluorescent microscope.
Of the 17 sera from histologically proven malignant glial neoplasm patients, 2 (11%) were positive for an autologous surface antibody reaction. Five (23%) of 21 were positive for an autologus cytoplasmic antibody, however, 10 (47%) of 21 of the sera gave a positive reaction for cross-reacting cytoplasmic antibodies when tested with a battery of tumor cells obtained from different patients with malignant glial tumors.
No reaction was observed with normal brain tissue. Absorption studies indicated the presence of a tumor-associated antigen.
This study demonstrated that certain patients with malignant gliomas possess circulating antibodies to cytoplasmic components of their own tumor cells. The fact that a number of sera cross-reacted with tumor cells obtained from different patients suggests that antigenic cross-reactivity exists between malignant glioma cells from different patients. It is suggested that with further refinement, immunofluorescent detection of antibodies could evolve as a useful diagnostic adjunct in malignant glioma.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Delpech B., Delpech A., Clément J., Laumonier R. Etude immunochimique et immunologique des tumeurs du cerveau humain. Int J Cancer. 1972 Mar 15;9(2):374–382. doi: 10.1002/ijc.2910090216. [DOI] [PubMed] [Google Scholar]
- Eggers A. E. Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas. Neurology. 1972 Mar;22(3):246–250. doi: 10.1212/wnl.22.3.246. [DOI] [PubMed] [Google Scholar]
- Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
- Hellström K. E., Hellström I. Immunity to neuroblastomas and melanomas. Annu Rev Med. 1972;23:19–38. doi: 10.1146/annurev.me.23.020172.000315. [DOI] [PubMed] [Google Scholar]
- Heppner G. H. Blocking antibodies and enhancement. Ser Haematol. 1972;5(4):41–66. [PubMed] [Google Scholar]
- Klein G., Klein E., Clifford P. Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Res. 1967 Dec;27(12):2510–2520. [PubMed] [Google Scholar]
- Lewis M. G., Sheikh K. M., Avis P., Whitehead V. M., Vera C. The indentification of foetal antigens in human bone marrow cells. Differentiation. 1974 Oct;2(5):307–311. doi: 10.1111/j.1432-0436.1974.tb00365.x. [DOI] [PubMed] [Google Scholar]
- MITTS M. G., WALKER A. E. AUTOIMMUNE RESPONSE TO MALIGNANT GLIAL TUMORS; PRELIMINARY OBSERVATIONS. Neurology. 1965 May;15:474–476. doi: 10.1212/wnl.15.5.474. [DOI] [PubMed] [Google Scholar]
- Morton D. L., Malmgren R. A. Human osteosarcomas: immunologic evidence suggesting an associated infectious agent. Science. 1968 Dec 13;162(3859):1279–1281. doi: 10.1126/science.162.3859.1279. [DOI] [PubMed] [Google Scholar]